Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Legend Biotech to Present Updated Long-Term and Real-World Evidence from CARVYKTI Clinical Program at the International Myeloma Society Annual Meeting
-
ATIF Holdings Limited Completes Acquisition of GoldCoin Labs, Expanding into Gold-Backed Digital Asset Sector
-
One and One Green Technologies to Present at the H.C. Wainwright 28th Annual Global Investment Conference
-
Ionic Digital Receives Base Load Provisional Classification in ERCOT’s Batch Zero Process
-
Amogy and LOTTE Fine Chemical Sign MOU to Advance Green Ammonia-to-Hydrogen and Ammonia-to-Power Solutions in South Korea
-
Circle8 Confirms Proposal for SThree plc, Advancing Global IT and Technology Strategy
-
Teads Expands Global CTV Offering with Whale TV Partnership
-
Aptera Motors Corp. to Participate in H.C. Wainwright 28th Annual Global Investment Conference
-
SERVPRO Expands Commitment to First Responders Through New Support of the Gary Sinise Foundation
-
DAV survey finds overwhelming opposition to TCAVA omnibus bill
-
Aprea Therapeutics to Present at H.C. Wainwright 28th Annual Global Investment Conference
-
Magnite and ITN Expand Partnership to Introduce Agentic AI Solution for Local Linear TV
-
New Apex Martech Matrix Targets a Critical Blind Spot in Martech Investment
-
Nanox Expands Latin American Presence with Nanox.ARC Distribution Agreement in Costa Rica
-
StoneX and DeltaTerra Develop New Synthetic Structure for Agency Credit Risk Transfer
-
Alignment Health’s Fifth Annual Survey Finds Seniors Falling Further Behind: Aging in Place Challenges Continue to Rise as Support Gaps Widen
-
Rhythm Pharmaceuticals Announces New Data Presentations at the European Society for Paediatric Endocrinology Meeting
-
ApolloMD Welcomes Scott O’Neil to Strategic Advisory Board
-
Electra Therapeutics Announces Initiation of a Phase 1 Trial of ELA822, a Novel SIRPγ-Specific Antibody Designed to Treat T Cell-Mediated Immune and Inflammatory Diseases
-
EV Realty Names Henrik Holland President to Accelerate National Expansion of Its Powered Properties® Platform
-
Muscogee Nation Gaming Enterprises Renews and Expands ZeroEyes Deployment Across New Properties
-
Adagene Announces that Third Arc Bio Has Selected First Lead Candidate under Amended Strategic Collaboration for Development of Masked CD3 T Cell Engagers Utilizing SAFEbody® Technology
-
BGI Group Showcases New Technologies for Advancing Personalized Health at 2026 Global New Product Launch Event
-
LEVEL8 Rethinks Business Travel with New Hybrid Hegent Carry-On Luggage Designed for Mobility
-
Pasqal and LG CNS partner to power Next-generation AI Data centers with quantum computing
-
Syntec Optics (Nasdaq: OPTX) Secures $5M Additional Recurring Orders for Diverse Range of U.S. Defense Platforms
-
Results of Scheme Meetings and EGM
-
Fusion Fuel Expands Al Shola Gas LPG Distribution Capacity with New Bobtail Expected to Generate Approximately $1.6 Million in Annual Recurring Revenue at Target Run-Rate
-
TTM Announces Proposed Offering of $500 Million of Senior Notes Due 2034
-
Scientist Home Future Health Trial Demonstrates Significant Reduction in Eczema Symptoms using Evidence-based Nutritional Therapy
-
Percona and Coroot Partner to Bring Full-Stack Observability to Open Source Database Environments
-
Ritedose Appoints Carolyn Berg as New Vice President of Strategic Growth
-
CAMP4 Therapeutics Receives Authorization in the United Kingdom for Phase 1/2 Human Clinical Trial of CMP-002 in Patients with SYNGAP1-Related Disorder
-
ESGold Advances Montauban Commissioning With Arrival of Key Processing Equipment
-
SKYX Signs Merger with Leading U.S. AI Smart Home Silicon Valley Backed Company Deako, Aiming to Lead the Smart Home, Builder & Hotel Markets with Their Combined Platform Technologies
-
SKYX Signs Merger with Leading U.S. AI Smart Home Silicon Valley Backed Company Deako, Aiming to Lead the Smart Home, Builder & Hotel Markets with Their Combined Platform Technologies
-
TG Therapeutics to Participate in the H.C. Wainwright 28th Annual Global Investment Conference
-
Delaware Court of Chancery Rules Empery Digital's Board Breached Its Fiduciary Duties
-
Prime Drink Group Announces First Closing of Private Placement
-
TERRA CLEAN ENERGY CORP ANNOUNCES COMMENCEMENT OF TRENCHING AND DRILL PAD CONSTRUCTION AT THE MARYSVALE URANIUM MINES PROJECT
-
Volatus Aerospace Awarded Canadian Defence Contract for Tactical ISR Uncrewed Aircraft Systems for up to 5,000 systems
-
Bombardier's Global 8000, the World’s Fastest Civil Aircraft, Received U.K. Civil Aviation Authority (CAA) Approval to Land at London City Airport
-
Cannabis Strategic Ventures, Inc. (OTC: NUGS) Signs Letter of Intent to Acquire Adport, a Mobile Out-of-Home Advertising Technology Business
-
Cloudera and Mistral Partner to Bring Specialized, Sovereign Intelligence to Enterprise Data
-
Delaware Court of Chancery Rules Empery Digital's Board Breached Its Fiduciary Duties
-
Immuneering to Present at the AACR Conference on Pancreatic Cancer, Highlighting Atebimetinib’s Dual Mechanism for Extended Survival
-
CervoMed Announces Initial Results from the Phase 2a Clinical Trial of Neflamapimod in Nonfluent Variant Primary Progressive Aphasia (nfvPPA) Have Been Accepted as a Late-Breaking Oral Session at ISFT
-
Bombardier's Global 8000, the World’s Fastest Civil Aircraft, Received U.K. Civil Aviation Authority (CAA) Approval to Land at London City Airport
-
Medicus Pharma Publishes Abridged Final Phase 2 SkinJect® Clinical Study Report (CSR) Results Identifying 200 µg D-MNA Patch as the Lead Development Dose
-
Helus Pharma to Participate at the Morgan Stanley 24th Annual Global Healthcare Conference in New York
